Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
Open Access
- 19 April 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (4), 1181
- https://doi.org/10.3390/jcm9041181
Abstract
Portal vein thrombus (PVT) is a challenge in liver transplantation. How PVT develops in cirrhotic patients who already have coagulopathy is unclear. This study aimed to investigate possible contributing factors to PVT in cirrhotic patients. A total of 349 cirrhotic patients who waited liver transplantation were included in this study and 48 of them had PVT. For all the patients, the mean age was 53.5 ± 9.0 year old, and 75.9% of the patients were male. There were 233 (66.8%) patients who had either hepatitis B or C. The mean Model For End-Stage Liver Disease (MELD) score was 16.4 ± 7.5. Eighteen of 48 patients with PVT and 145 of 301 patients without PVT received liver transplantation. Multivariate analysis showed that low protein S level (hazard ratio = 2.46, p = 0.017) was the only independent risk factor for PVT development. Protein S deficiency also demonstrated prognostic value on short-term survival, not only for cirrhotic patients awaiting liver transplantation (69.9% versus 84.1% at 1 year survival, p = 0.012), but also for the patients having liver transplantation (70.4% versus 84.8% at 1 year survival, p = 0.047). In conclusion, protein S level was an independent risk factor for PVT development in decompensated cirrhotic patients, and protein S deficiency was also a prognostic factor for the patients waiting for liver transplantation.This publication has 40 references indexed in Scilit:
- Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosisJournal of International Medical Research, 2013
- Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcomeHPB, 2007
- Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulationGut, 2005
- Infection, coagulation, and variceal bleeding in cirrhosisGut, 2005
- Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosisJournal of Hepatology, 2004
- Modulation of Portal Graft Inflow: A Necessity in Adult Living-Donor Liver Transplantation?Annals of Surgery, 2003
- Hypercoagulability SyndromesArchives of Internal Medicine, 2001
- A model to predict survival in patients with end-stage liver diseaseHepatology, 2001
- Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?Gut, 2000
- The incidence of portal vein thrombosis at liver transplantationHepatology, 1992